Friday 6 November 2026
Export COO’s income statement to Excel — free account
The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.
- Revenue
- +0.56%
- EPS
- +357.1%
- Free cash flow
- +66.0%
- Total debt
- +2.66%
Quarter to July 2026, against a year earlier
62.70
0.81
−1.28%
Follow COO
Alert me
The Cooper Companies, Inc. (COO) SEC filings, changes and red flags
Red flags
-
Officer departure
The Cooper Companies, Inc. reported the departure of its Chief Executive Officer
-
Auditor’s opinion
The Cooper Companies, Inc.’s auditor’s report on its 10-K is not a clean opinion, or points to a restatement
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of October 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated December 6, 2024 expressed an adverse opinion on the effectiveness of the Company's internal control over financial reporting.
-
Material weakness
The Cooper Companies, Inc.’s 10-Q reports a material weakness in internal control over financial reporting
Based on management’s evaluation (with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer)), as of the end of the period covered by this report, due to the material weakness described below, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the Exchange Act)) are not effective as of April 30, 2025 to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 8-K | Oct 27, 2026 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | Officer departure | |
| 10-Q | Jul 31, 2026 |
P1I2: 16 added · 4 removed · 24 modified P2I1A: no material changes, the filing says |
||
| 8-K | Sep 9, 2026 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Apr 30, 2026 |
P1I2: 11 added · 3 removed · 30 modified P2I1A: no material changes, the filing says |
||
| 8-K | Jun 4, 2026 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | May 4, 2026 | 5.02 Departure or appointment of directors or officers | ||
| 8-K | Apr 7, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 10-Q | Jan 31, 2026 | |||
| 8-K | Mar 5, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 3, 2026 | 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 22, 2025 | 1.01 Entry into a material definitive agreement; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 9, 2025 | 5.02 Departure or appointment of directors or officers | ||
| 10-K | Oct 31, 2025 |
1: 15 added · 3 removed · 31 modified 1A: 3 added · 53 modified 7: 11 added · 8 removed · 30 modified |
||
| 8-K | Dec 4, 2025 | 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jul 31, 2025 |
P1I2: 6 added · 3 removed · 18 modified P2I1A: no material changes, the filing says |
||
| 8-K | Aug 27, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Apr 30, 2025 | Material weakness | ||
| 8-K | May 29, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jan 31, 2025 | |||
| 8-K | Mar 6, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Oct 31, 2024 | Auditor’s opinion | ||
| 8-K | Dec 5, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jul 31, 2024 | |||
| 8-K | Aug 28, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | May 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 29, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 6, 2023 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits |